
|Articles|October 25, 2012
Risk of VTE Increased in New Users of Drospirenone
A retrospective cohort study of more than a half million new users of hormonal contraception shows that drospirenone is associated with a higher risk of thrombotic events than contraceptives containing low-dose estrogen.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Minipad-based HPV testing shows promise for cervical cancer screening
2
Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy
3
Study data highlight trade-offs of testing for pregnancy too soon
4
Fionnuala McAuliffe, MD, highlights importance of timely breastfeeding discussions with patients
5









